All Pathways
Obstetrics & GynecologyManagement

Pelvic Inflammatory Disease Management (CDC 2021)

Pelvic Inflammatory Disease Management (CDC 2021): Suspected PID → Diagnostic Criteria → Diagnostic Workup → Severity Assessment → Inpatient Criteria.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected PID

    Lower abdominal/pelvic pain in sexually active patient

    1. Action

      Diagnostic Criteria

      Minimum criteria for empiric treatment

      • MINIMUM CRITERIA (any one):
      • - Cervical motion tenderness
      • - Uterine tenderness
      • - Adnexal tenderness
      • ADDITIONAL CRITERIA (support diagnosis):
      • - Temp >38.3°C (101°F)
      • - Mucopurulent cervical discharge
      • - WBC on wet prep
      • - Elevated ESR or CRP
      • - Lab evidence of GC or chlamydia
      1. Action

        Diagnostic Workup

        Rule out emergencies, obtain cultures

        • Pregnancy test (rule out ectopic)
        • NAAT for GC and chlamydia
        • Wet prep/vaginal microscopy
        • HIV testing
        • Consider: CBC, CRP, urinalysis
        • Pelvic ultrasound if TOA suspected
        1. Decision

          Severity Assessment

          Inpatient vs outpatient management

          1. Action

            Inpatient Criteria

            Admit if any present

            • Surgical emergency not excluded (appendicitis, ectopic)
            • Pregnant
            • Unable to tolerate oral meds (N/V)
            • Severe illness, high fever, peritonitis
            • Tubo-ovarian abscess
            • Failed outpatient therapy
            1. Action

              Inpatient IV Treatment

              Parenteral regimens

              • REGIMEN A:
              • Ceftriaxone 1g IV q24h + Doxycycline 100mg IV/PO q12h + Metronidazole 500mg IV/PO q12h
              • REGIMEN B:
              • Cefoxitin 2g IV q6h + Doxycycline 100mg IV/PO q12h
              • Transition to oral after 24-48h improvement
              1. Action

                Follow-Up

                Essential for all patients

                • 72-hour follow-up for clinical improvement
                • Partner treatment (expedited partner therapy)
                • STI counseling and education
                • Retest for GC/chlamydia in 3 months
                • Counsel on fertility implications
                1. Outcome

                  Resolution

                  Complete antibiotic course, test of cure

          2. Action

            Outpatient Treatment

            CDC 2021 recommended regimen

            • Ceftriaxone 500mg IM x1 (1g if ≥150kg)
            • PLUS Doxycycline 100mg PO BID x 14 days
            • PLUS Metronidazole 500mg PO BID x 14 days
            • Alternative cephalosporin + probenecid options available
            • Follow-up in 72 hours essential
            1. Warning

              Partner Notification

              All sex partners in past 60 days

              • Evaluate and treat presumptively
              • Expedited partner therapy if allowed
              • Abstain from intercourse until treatment complete
        2. Decision

          Tubo-Ovarian Abscess?

          Ultrasound or clinical suspicion

          1. Action

            TOA Management

            May require drainage

            • IV antibiotics initially
            • Consider interventional drainage if >6-8cm
            • Surgical management if ruptured
            • Follow with imaging for resolution
            • May require prolonged antibiotics

Guideline Source

CDC Sexually Transmitted Infections Treatment Guidelines 2021

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • PID is a clinical diagnosis - no gold standard test
  • Treatment empiric - culture results take days
  • Partner notification essential
  • Tubo-ovarian abscess requires additional management

Applicable Regions

USGlobal
Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Pelvic Inflammatory Disease Management (CDC 2021)?

The Pelvic Inflammatory Disease Management (CDC 2021) is a management clinical algorithm for Obstetrics & Gynecology. It provides a structured decision tree to guide clinical decision-making, based on CDC Sexually Transmitted Infections Treatment Guidelines 2021.

What guideline is the Pelvic Inflammatory Disease Management (CDC 2021) based on?

This algorithm is based on CDC Sexually Transmitted Infections Treatment Guidelines 2021 (DOI: 10.15585/mmwr.rr7004a1).

What are the limitations of the Pelvic Inflammatory Disease Management (CDC 2021)?

Known limitations include: PID is a clinical diagnosis - no gold standard test; Treatment empiric - culture results take days; Partner notification essential; Tubo-ovarian abscess requires additional management. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Pelvic Inflammatory Disease Management (CDC 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free